Reider Paul
SEC insider (Form 3/4/5 filer). CIK 0001970033. Chief Commercial Officer at Coherus BioSciences, Inc. (CHRS). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 20, 2025. Located in REDWOOD CITY, CA.
Companies Reider Paul has filed insider reports for
- Coherus BioSciences, Inc. (CHRS): Officer, Chief Commercial Officer
Reider Paul
CIK: 0001970033
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (75.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CHRS
Coherus BioSciences, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 20, 2025CHRS
Coherus BioSciences, Inc.
Tax PaymentDirect4.9K shares at avg. $1.39$7K - Jan 4, 2025CHRS
Coherus BioSciences, Inc.
Tax PaymentDirect2.3K shares at avg. $1.66$4K - Jan 3, 2025CHRS
Coherus BioSciences, Inc.
AwardDirectStock Option (Right to Buy)
160K shares- - Dec 13, 2024CHRS
Coherus BioSciences, Inc.
Tax PaymentDirect2.1K shares at avg. $1.61$3K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 20, 2025 | CHRS Coherus BioSciences, Inc. | Tax Payment | 4,858 | $1.39 | $6,753 | Direct |
| Jan 4, 2025 | CHRS Coherus BioSciences, Inc. | Tax Payment | 2,277 | $1.66 | $3,780 | Direct |
| Jan 3, 2025 | CHRS Coherus BioSciences, Inc. | Award Stock Option (Right to Buy) | 160,000 | - | - | Direct |
| Dec 13, 2024 | CHRS Coherus BioSciences, Inc. | Tax Payment | 2,073 | $1.61 | $3,338 | Direct |
1-4 of 4 transactions